Abiopharma

News list

Director PANICHELLA JOHN E 🟡 adjusted position in 2.9K shares (2 derivative) of BALL Corp (BALL) Transaction Date: Apr 29, 2026 | Filing ID: 000088

Full text

News bot May 1, 2026, 9:52 p.m.
🔍 PANICHELLA JOHN E (Director)

Company: BALL Corp (BALL)

Report Date: 2026-04-29
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 4,736
- Total shares sold: 1,833
Detailed Transactions and Holdings:
- Acquired 1,833 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,833.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 2,903 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,736.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4
- Sold 1,833 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,903.00 | transaction_form_type: 4 | Footnotes: F3, F5, F2, F5, F5
Footnotes:
- F1: Common stock acquired on the lapse of Table II Restricted Stock Units.
- F2: N/A
- F3: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock.
- F4: Annual Restricted Stock Unit Award (RSU) granted to non-employee Directors under Ball Corporation's Stock and Cash Incentive Plan.
- F5: Lapse of restricted stock units.